| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.5312/WJO.V3.I12.212 |
| P8608 | Fatcat ID | release_rzq2rqqglze7xc7ggur5aefene |
| P932 | PMC publication ID | 3557323 |
| P698 | PubMed publication ID | 23362465 |
| P5875 | ResearchGate publication ID | 235383738 |
| P2093 | author name string | Yan Xiu | |
| Lianping Xing | |||
| Brendan F Boyce | |||
| P2860 | cites work | DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells | Q24290803 |
| Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis | Q24564656 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development | Q24616861 | ||
| DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features | Q24672682 | ||
| Impaired differentiation of osteoclasts in TREM-2-deficient individuals | Q24672735 | ||
| p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein | Q28144577 | ||
| Matrix-embedded cells control osteoclast formation | Q28247746 | ||
| Evidence for osteocyte regulation of bone homeostasis through RANKL expression | Q28247757 | ||
| Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis | Q28267970 | ||
| Interleukin-32: a cytokine and inducer of TNFalpha | Q28303648 | ||
| A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function | Q28305026 | ||
| RANKL-induced DC-STAMP is essential for osteoclastogenesis | Q28504881 | ||
| DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells | Q28506839 | ||
| Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL | Q28508494 | ||
| Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation | Q28511207 | ||
| The intracellular domain of CD44 promotes the fusion of macrophages | Q28577304 | ||
| ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo | Q28587581 | ||
| ADAM8: a novel osteoclast stimulating factor | Q28588620 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells | Q28589731 | ||
| Shared principles in NF-kappaB signaling | Q29547234 | ||
| Genetic regulation of osteoclast development and function | Q29617421 | ||
| Regulation of resting intracellular Ca(2+) concentration of ventricular myocytes by beta(3)-adrenoceptor and its signaling pathway in rats with experimental heart failure | Q33499592 | ||
| The role of calcium release activated calcium channels in osteoclast differentiation | Q33608899 | ||
| Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. | Q33611312 | ||
| Identification of an inducible surface molecule specific to fusing macrophages | Q33656414 | ||
| NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis | Q33768994 | ||
| MFR, a putative receptor mediating the fusion of macrophages | Q33781252 | ||
| Specific cellular responses to alpha-tocopherol | Q33950221 | ||
| Recent advances in understanding the mechanisms of osteoclast precursor fusion | Q34033604 | ||
| Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). | Q34222920 | ||
| NF-κB signaling participates in both RANKL- and IL-4-induced macrophage fusion: receptor cross-talk leads to alterations in NF-κB pathways. | Q35147834 | ||
| Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
| Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1 | Q35863762 | ||
| Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion | Q36003737 | ||
| An essential role for the association of CD47 to SHPS-1 in skeletal remodeling | Q36058860 | ||
| CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts | Q36173877 | ||
| CD44 occupancy prevents macrophage multinucleation | Q36288187 | ||
| Osteoclast precursors, RANKL/RANK, and immunology | Q36324916 | ||
| CD44 is a determinant of inflammatory bone loss | Q36403383 | ||
| TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood | Q36757010 | ||
| Calcium signalling in lymphocyte activation and disease | Q36912139 | ||
| Calcium signalling and calcium transport in bone disease | Q37056471 | ||
| Osteoclast cell fusion: mechanisms and molecules | Q37143253 | ||
| Essential role of DAP12 signaling in macrophage programming into a fusion-competent state | Q37171072 | ||
| Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. | Q37178911 | ||
| NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). | Q37302319 | ||
| Macrophage fusion: molecular mechanisms | Q37315593 | ||
| Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor | Q37350732 | ||
| NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism | Q37363042 | ||
| Molecular mediators of macrophage fusion | Q37592510 | ||
| ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+ entry in the immune system and beyond. | Q37597624 | ||
| Regulation of osteoclast precursors in inflammatory bone loss. | Q37624507 | ||
| CCN family 2/connective tissue growth factor (CCN2/CTGF) promotes osteoclastogenesis via induction of and interaction with dendritic cell-specific transmembrane protein (DC-STAMP). | Q38341546 | ||
| Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan | Q40195873 | ||
| RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis | Q40271536 | ||
| CTGF/Hcs24 interacts with the cytoskeletal protein actin in chondrocytes | Q40684978 | ||
| Sequential requirements for SCL/tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development | Q40866815 | ||
| Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling | Q43142702 | ||
| Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes | Q43180966 | ||
| NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis | Q44049672 | ||
| Effect of CD44 deficiency on in vitro and in vivo osteoclast formation | Q45172592 | ||
| Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells. | Q45986467 | ||
| Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. | Q46112460 | ||
| Development of foreign body giant cells in response to implantation of Spongostan as a scaffold for cartilage tissue engineering | Q47717867 | ||
| Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis | Q47761859 | ||
| Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation | Q48537793 | ||
| Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. | Q50335960 | ||
| RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. | Q51032592 | ||
| Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
| Vitamin E decreases bone mass by stimulating osteoclast fusion. | Q53172611 | ||
| The influence of interleukin-32γ on osteoclastogenesis with a focus on fusion-related genes. | Q54551276 | ||
| Induction of DC-STAMP by Alternative Activation and Downstream Signaling Mechanisms | Q57675118 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor | Q71656908 | ||
| Two novel genes FIND and LIND differentially expressed in deactivated and Listeria-infected human macrophages | Q73857061 | ||
| CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation | Q74241718 | ||
| Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells | Q78340427 | ||
| Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction | Q79382486 | ||
| v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation | Q79383955 | ||
| Abundant expression of tetraspanin CD9 in activated osteoclasts in ovariectomy-induced osteoporosis and in bone erosions of collagen-induced arthritis | Q80695379 | ||
| Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells | Q83454126 | ||
| Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP | Q85077877 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 212-222 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | World journal of orthopedics | Q27724018 |
| P1476 | title | Osteoclast fusion and regulation by RANKL-dependent and independent factors | |
| P478 | volume | 3 |
| Q92702961 | A Sub-Clone of RAW264.7-Cells Form Osteoclast-Like Cells Capable of Bone Resorption Faster than Parental RAW264.7 through Increased De Novo Expression and Nuclear Translocation of NFATc1 |
| Q39372845 | Ablation of Y1 receptor impairs osteoclast bone-resorbing activity |
| Q37412571 | Age-related effects on osteoclastic activities after orthodontic tooth movement |
| Q38711081 | Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions |
| Q37377385 | Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling |
| Q49178922 | An improved metrics for osteoclast multinucleation |
| Q47407845 | Atorvastatin inhibits osteoclast differentiation by suppressing NF-κB and MAPK signaling during IL-1β-induced osteoclastogenesis |
| Q53793555 | Bone resorptive activity of human peripheral blood mononuclear cells after fusion with polyethylene glycol. |
| Q33567830 | Can denosumab be a substitute, competitor, or complement to bisphosphonates? |
| Q40332532 | DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption. |
| Q38178193 | DC-STAMP, the key fusion-mediating molecule in osteoclastogenesis. |
| Q48088472 | Dual-specificity tyrosine phosphorylation-regulated kinase 2 regulates osteoclast fusion in a cell heterotypic manner. |
| Q52779703 | Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation. |
| Q35236489 | FOXO1 deletion reduces dendritic cell function and enhances susceptibility to periodontitis |
| Q35164358 | FOXO1 mediates RANKL-induced osteoclast formation and activity |
| Q54978831 | Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation. |
| Q38787084 | Ginger hexane extract suppresses RANKL-induced osteoclast differentiation |
| Q58750310 | Hesperetin Prevents Bone Resorption by Inhibiting RANKL-Induced Osteoclastogenesis and Jnk Mediated Irf-3/c-Jun Activation |
| Q91639069 | Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions |
| Q41188020 | Immunohistochemical detection of the receptor activator of nuclear factor Kappa B ligand and c-fos in giant cell granuloma |
| Q38854289 | Impaired osteoclast homeostasis in the cystatin B-deficient mouse model of progressive myoclonus epilepsy |
| Q54325518 | Inhibition mechanism of Qingluo Tongbi Granule () on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats. |
| Q100386686 | Lactobacillus Fermentum ZS40 prevents secondary osteoporosis in Wistar Rat |
| Q104064564 | Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis |
| Q51654903 | Modulation of unloading-induced bone loss in mice with altered ERK signaling. |
| Q35076418 | Molecular signaling pathways mediating osteoclastogenesis induced by prostate cancer cells |
| Q98386302 | Mycobacterium tuberculosis infection increases the number of osteoclasts and inhibits osteoclast apoptosis by regulating TNF-α-mediated osteoclast autophagy |
| Q37448881 | NADPH oxidase gp91(phox) contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1 |
| Q61814977 | Ninjurin1 positively regulates osteoclast development by enhancing the survival of prefusion osteoclasts |
| Q88039773 | OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9 |
| Q35188522 | Obatoclax regulates the proliferation and fusion of osteoclast precursors through the inhibition of ERK activation by RANKL |
| Q33723296 | Osteoclast fusion is based on heterogeneity between fusion partners |
| Q41184194 | Osteoprotegerin exposure at different stages of osteoclastogenesis differentially affects osteoclast formation and function. |
| Q26824476 | Pathobiology of Paget's Disease of Bone |
| Q91726950 | Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment |
| Q38983345 | Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor |
| Q44166987 | Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP. |
| Q35595132 | Proteomic study of different culture medium serum volume fractions on RANKL-dependent RAW264.7 cells differentiating into osteoclasts |
| Q40791962 | Retinal pigment epithelial cell multinucleation in the aging eye - a mechanism to repair damage and maintain homoeostasis. |
| Q92280926 | Role of the captured retroviral envelope syncytin-B gene in the fusion of osteoclast and giant cell precursors and in bone resorption, analyzed ex vivo and in vivo in syncytin-B knockout mice |
| Q96685742 | Switch of macrophage fusion competency by 3D matrices |
| Q52893619 | The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool. |
| Q33669039 | The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts. |
| Q97523968 | The role of indoleamine 2,3 dioxygenase 1 in the osteoarthritis |
| Q58805042 | Wear particles enhance autophagy through up-regulation of CD147 to promote osteoclastogenesis |
Search more.